Intracellular trafficking of the α(IIb)β3 receptor antagonist, abciximab, in normal and Glanzmann's disease megakaryocytes

British Journal of Haematology

Volumn 107, Issue 4, 1999, Pages 720-730

  Massé, Jean Marc ^a   Perlemuter, Katy ^a   Debili, Najet ^b   Letestu, Rémi ^b   Castaigne, Alain ^a   Cramer, Elisabeth M ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Abciximab; Megakaryocytes; Platelet inhibitors; (IIb) 3

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ANTIBODY LABELING; ARTICLE; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG BINDING; GLANZMANN DISEASE; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MEGAKARYOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; SECRETORY GRANULE; THROMBOCYTE; CELL CULTURE; ELECTRON MICROSCOPY; IMMUNOBLOTTING; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; BIOLOGICAL TRANSPORT; CELLS, CULTURED; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN FAB FRAGMENTS; MEGAKARYOCYTES; MICROSCOPY, ELECTRON; PLATELET AGGREGATION INHIBITORS; THROMBASTHENIA;

EID: 0033233210     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01768.x     Document Type: Article

References (34)

1. Behnke, O. (1968) An electron microscope study of megakaryocytes of rat bone marrow: the development of the demarcation membrane system and the platelet surface coat. Journal of Ultrastructural Research, 24, 412-433.
2. Berger, G., Massé, J.M. & Cramer, E.M. (1996) Alpha-granule membrane mirrors the platelet plasma membrane and contains GPIb, IX and V. Blood, 87, 1385-1395.
3. Bihour, C., Durrieu-Jais, C., Macchi, L., Poujol, C., Coste, P., Besse, P., Nurden, P. & Nurden, A.T. (1999) Expression of markers of platelet activation and the interpatient variation in response to abciximab. Arteriosclerosis and Thrombosis: Vascular Biology, 19, 212-219.
4. Breton-Gorius, J. & Vainchenker, W. (1986) Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryocytes and morphological aspects of their maturation. Seminars in Hematology, 23, 43-67.
5. Choi, E.S., Nichol, J.L., Hokom, M.M., Hornkoh, A.C. & Hunt, P. (1995) Platelet generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood, 85, 402-413.
6. Christopoulos, C., Mackie, A., Lahiri, A. & Machin, S. (1993) Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa. Blood Coagulation and Fibrinolysis, 4, 729-737.
7. Coller, B.S. (1985) A new murine monoclonal antibody reports an activation dependent change in the conformation and/or micro-environment of the platelet glycoprotein IIb-IIIa complex. Journal of Clinical Investigation, 76, 101-108.
8. Coller, B.S. (1997) GPIIb-IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thrombosis and Haemostasis, 77, 730-735.
9. Coller, B.S., Folts, J.D., Smith, S.R., Scudder, L.E. & Jordan, R. (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb-IIIa receptor: correlation with bleeding time, platelet aggregation, and blockade of GPIIb-IIIa receptors. Circulation, 80, 1766-1774.
10. Coller, B.S., Peerschke, E.I., Scudder, L.E. & Sullivan, C.A. (1983) A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. Journal of Clinical Investigation, 72, 325-338.
11. Cramer, E.M., Debili, N., Martin, J.F., Gladwin, A.M., Breton-Gorius, J., Harrison, P., Savidge. G.F. & Vainchenker, W. (1989) Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes. Blood, 73, 1123-1129.
12. Cramer, E.M., Norol, F., Guichard, J., Breton-Gorius, J., Vainchenker, W., Massé, J.M. & Debili, N. (1997) Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood, 89, 2336-2346.
13. Cramer, E.M., Savidge, G., Vainchenker, W., Berndt, M.C., Pidard, D., Caen, J.P., Massé, J.M. & Breton-Gorius, J. (1990) Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes, Blood, 65, 1220-1227.
14. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P. & Vainchenker, W. (1995) The Mpl ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood, 86, 2516-2526.
15. Faulds, D. & Sorkin, E.M. (1994) Abciximab (c7E3 Fab): a review of its pharmacology and therapeutic potential in ischaemic heart disease. Drugs, 48, 583-598.
16. Fitzgerald, D.J., Roy, L., Catella, F. & Fitzgerald, G.A. (1986) Platelet activation in unstable coronary disease. New England Journal of Medicine, 315, 983-989.
17. Fuster, V., Badimon, L., Cohen, M., Ambrose, J.A., Badimon, J.J. & Chesebro, J. (1988) Insights into the pathogenesis of acute ischemic syndromes. Circulation, 77, 1213-1220.
18. George, J.N. (1990) Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of α-granule proteins. Blood, 76, 859-870.
19. George, J.N., Saucerman, S., Levine, S.P., Knieriem, L.K. & Bainton, D.F. (1985) Immunoglobulin G is a platelet alpha granule-secreted protein. Journal of Clinical Investigation, 76, 2020-2025.
20. Ginsberg, M.H., Xiaoping, D., O'Toole, T.E., Loftus, J.C. & Plow, E.F. (1993) Platelet integrins. Thrombosis and Haemostasis, 70, 87-93.
21. Gogstad, G.O., Brosstad, F., Krutnes, M.B., Hagen, I. & Solum, N.O. (1982) Fibrinogenbinding properties of the human platelet glycoprotein IIb-IIIa complex: a study using crossed radio-immuno-electrophoresis. Blood, 60, 663-671.
22. Handagama, P., Bainton, D.F., Jacques, Y., Conn, M.T., Lazarus, R.A. & Shuman, M.A. (1993a) Kristin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet α-granules. Journal of Clinical Investigation, 91, 193-200.
23. Handagama, P.J., Scarborough, R.M., Shuman, M.A. & Bainton, D.F. (1993b) Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by glycoprotein IIb-IIIa. Blood, 82, 135-138.
24. Handagama, P.J., Shuman, M.A. & Bainton, D.F. (1989) Incorporation of intravenously injected albumin, IgG and fibrinogen in guinea pig megakaryocyte granules. Journal of Clinical Investigation, 84, 73-82.
25. Harrison, P., Wilbourn, B., Debili, N., Vainchenker, W., Breton-Gorius, J., Lawrie, A.S., Masse, J.M., Savidge, G.F. & Cramer, E.M. (1989) Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. Journal of Clinical Investigation, 84, 1320-1324.
26. Hynes, R.O. (1987) Integrins: a family of cell surface receptors. Cell, 48, 549-554.
27. Jordan, R.E., Wagner, C.L. & Mascelli, M. (1996) Preclinical development of c7E3 Fab; a mouse/human chimeric monoclonal antibody fragment that inhibits platelet function by blockade of GPIIb-IIIa receptors with observations on the immunogenicity of c7E3 Fab in human. Adhesion Receptors as Therapeutic Targets (ed. by M. A. Horton), pp. 281-305. CRC Press, Boca Raton.
28. Knight, D.M., Wagner, C., Jordan, R., McAleer, M., DeRita, R., Fass, D.N., Coller, B.S., Weisman, H.F. & Ghrayeb, J. (1995) The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Journal of Molecular Immunology, 32, 1271-1281.
29. Nurden, P., Poujol, C., Durrieu-Jais, C., Winckler, J., Combrie, R., Macchi, L., Bihour, C., Wagner, C., Jordan, R. & Nurclen, A.T. (1999) Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab): flow and endocytic mechanisms contribute to the transport. Blood, 93, 1622-1633.
30. Poujol, C., Nurden, A.T. & Nurden, P. (1997) Ultrastructural analysis of the distribution of the vitronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the alpha-granule membrane. British Journal of Haematology, 96, 823-835.
31. The CAPTURE Investigators (1997) Randomised placebo-controlled trial of effect of abciximab before and during coronary intervention in refractory unstable angina. Lancet, 349, 1429-1435.
32. The EPIC Investigators (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb-IIIa receptor in high-risk coronary angioplasty. New England Journal of Medicine, 330, 956-961.
33. The EPILOG Investigators (1997) Platelet glycoprotein IIb-IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. New England Journal of Medicine, 336, 1689-1696.
34. Wendling, F., Maraskovsky, E., Debili, N., Florindo, C., Tepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D. & Vainchenker, W. (1994) A mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 369, 571-574.